Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
Bindiya Thakkar(Beth Israel Deaconess Medical Center), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Maria Vamvini(Joslin Diabetes Center), Konstantinos N. Aronis(University of Pittsburgh Medical Center), Kelsey Shields(Beth Israel Deaconess Medical Center)
Cited by 185
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k